VLA
Click for more information
0.00% $1.75 viralytics limited

Latest clinical trial results, page-11

  1. DavieJones
    246 Posts.
    lightbulb Created with Sketch. 26
    clock Created with Sketch.
    11/04/18
    22:44
    Post #: 32391904
    Hi Lopez

    The Keynote 200 trial looks like it is tracking well and the upregulation of PD-L1 in NSCLC and bladder cancer looks promising.

    I'm still disappointed at the pace of the MITCI & CAPRA trials .... still recruiting very slowly but the results are looking excellent.

    I think today's announcement will help to clarify the results from the presentation.

    GLTAH
    VLA Price at posting: $1.69 Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EBR FDA commences substantive review of EBR’s PMA application
right-arrow Created with Sketch.
LU7 Strong preliminary feasibility for Bécancour Lithium Refinery
right-arrow Created with Sketch.
NEWS New insights revealed: high-grade lode gold/copper deposit model for El Dovio Project reinterpreted—see the potential
right-arrow Created with Sketch.
NEWS Major acquisition of high-grade antimony deposit, find out who's securing global assets
right-arrow Created with Sketch.
NEWS Major shallow copper-silver discovery at Junction Prospect confirmed with high-grade intercepts
right-arrow Created with Sketch.
NEWS High-grade antimony mineralization confirmed at Ricciardo with potential 1km strike length
right-arrow Created with Sketch.
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.